The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura
Indian pharmaceutical companies are facing a changing landscape with growth in specialty drugs and shifting generic market shares. Leading players like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus are experiencing a mix of success and challenges. Specialty medicines and exclusive launches are driving sales, but competition and regulations are shaping their strategies..